Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of a GLP-1 Agonist to Appetite Regulation, Metabolism and Body Composition in Subjects With Prader-Willi Syndrome.

NCT00551343 is registered in ClinicalTrials.gov with Garvan Institute of Medical Research as lead sponsor.

NCT NCT00551343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of a GLP-1 Agonist to Appetite Regulation, Metabolism and Body Composition in Subjects With Prader-Willi Syndrome.
Lead sponsor
Garvan Institute of Medical Research
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2007
Completion date
September 30, 2008
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prader-willi syndrome